Abnormalities in immunoregulatory CD5+ B cells precede the diagnosis of multiple myeloma.
Paglieroni
T
T
Sacramento Medical Foundation Center for Blood Research, Sutter Cancer Center, University of California Davis Medical Center 95816-7089.
MacKenzie
M R
MR
Caggiano
V
V
D000917:Antibody Formation; D015703:Antigens, CD / Q000032:analysis*; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte / Q000032:analysis; D016175:B-Lymphocyte Subsets / Q000276:immunology*; D018956:CD5 Antigens; D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000276:immunology*; D010265:Paraproteinemias / Q000175:diagnosis / Q000276:immunology*; D010954:Plasmacytoma / Q000175:diagnosis / Q000276:immunology*; D011043:Pokeweed Mitogens; D011230:Precancerous Conditions / Q000175:diagnosis / Q000276:immunology*
D015703:Antigens, CD; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte; D018956:CD5 Antigens; D011043:Pokeweed Mitogens